Tarsus Pharmaceuticals TARS
NASDAQ TARS
$76.03 +2.19 (+2.97%)
As of: Nov 11, 2026 · 10:01 AM EST

Tarsus Pharmaceuticals (TARS) Cash from Financing Activities (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) recorded Cash from Financing Activities of $127.81 million in Q3 2026, compared with $2.56 million a year earlier.

Analysis

Tarsus Pharmaceuticals (TARS) Cash from Financing Activities (2019 - 2026) Analysis & Trends

On a TTM basis, Tarsus Pharmaceuticals' Cash from Financing Activities came in at $134.63 million as of Sep 30, 2026, down 6.5% year-over-year; for FY2025, it was $143.39 million, down 7.3% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $154.66 million in FY2024 (+18.8%), $130.18 million in FY2023 (+38.5%), $93.99 million in FY2022 and $21,000 in FY2021 (-100.0%).
  • The Q3 2026 figure is the highest quarterly Cash from Financing Activities since Q1 2025.
  • On a year-over-year basis, Cash from Financing Activities rose in three of the last seven quarters, with growth averaging 13.6%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 300.9% in Q3 2025, against a decline of 99.4% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.3 million (Q2 2026), $1.2 million (Q1 2026) and $2.31 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -8.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.82 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -1.53 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.51 Bn
10 Tarsus Pharmaceuticals 3.64 Bn 2.07 Bn 180.68 Mn 127.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 127.81 Mn
Jun 30, 2026 3.30 Mn
Mar 31, 2026 1.20 Mn
Dec 31, 2025 2.31 Mn
Sep 30, 2025 2.56 Mn
Jun 30, 2025 1.95 Mn
Mar 31, 2025 136.56 Mn
Dec 31, 2024 2.93 Mn
Sep 30, 2024 639,000.00
Jun 30, 2024 42.32 Mn
Mar 31, 2024 108.77 Mn
Dec 31, 2023 19.76 Mn
Sep 30, 2023 104.89 Mn
Jun 30, 2023 510,000.00
Mar 31, 2023 5.01 Mn
Dec 31, 2022 264,000.00
Sep 30, 2022 -136,000.00
Jun 30, 2022 74.73 Mn
Mar 31, 2022 19.13 Mn
Dec 31, 2021 -74,000.00
API Access

Tarsus Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TARS&period=max&api_key=YOUR_API_KEY